Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px
Document › Details

MCG Motion Capture GmbH. (10/22/19). "Press Release: Motion Capture Group Retains Biotech Alliances International to Raise Series A $15 Million Financing Round". Heidelberg & San Francisco, CA.

Organisations Organisation MCG Motion Capture GmbH (Motion Capture Group)
  Organisation 2 Biotech Alliances International Inc.
Products Product digital health
  Product 2 investment banking
Index terms Index term MCG Motion Capture–Biotech Alliances International: investment banking, 201910– service excl for planned $15m Series A Round of MCG
  Index term 2 MCG Motion Capture–SEVERAL: investment, 201910– PLANNED financing round Series A $15m
Persons Person Voss, Hartmut (MCG Motion Capture 201910 Managing Director)
  Person 2 Brinkhaus, Franck (Biotech Alliances International Inc 201810 CEO before Woodside Capital Partners)
     


Proceeds to be used for the clinical validation of pioneering real-world motion analysis solutions and MotionMarkers for chronic movement disorders


Motion Capture Group (MCG), a motion analysis and digital care company, today announced that it has exclusively contracted the investment bank Biotech Alliances International Inc. for its planned $15 million Series A capital raise.

MCG is pioneering the discovery of clinically relevant markers of movement disorders (so-called MotionMarkers) which are captured under real- world conditions using innovative wearable sensors. Via a sophisticated digital health infrastructure, MotionMarkers from patients with chronic motion conditions are continuously monitored and translated into clinically actionable, personalized treatment decisions. The Company focuses on motion-related conditions such as chronic back pain, knee and hip arthroplasty or neurodegenerative diseases, such as Parkinson`s disease or stroke. These conditions are among the main cost-drivers in healthcare spending worldwide.

At present, MCG is working on a new generation of dynamic motion analysis solutions based on posture and gait sensors combined with cloud-based analytics. The goal is to improve both treatment outcomes and quality and to avoid unnecessary healthcare costs. MCG´s proprietary MotionMarker solutions cover all aspects of the healthcare cycle: prevention, diagnosis, treatment and sports/well-being.

For the patient care setting, MCG´s solutions allow for the prevention of and recovery from musculoskeletal conditions, including knee, hip and back conditions. For the pharma industry, MCG provides MotionMarkers as validated clinical endpoints for drug development programs to establish objective, measurable drug responses.

"Our approach is based on extensive experience and data generated with our KOLs and the current medical gold standard for spine motion analysis outside the lab," said Hartmut Voss, Co-CEO of Motion Capture Group. "MCG´s next-generation spine sensor, MCGposture, analyzes the extension, flexion, rotation, and lateral inclination of the spine for up to 24 hours. The second product in our pipeline is MCGgait, a high quality in-sole sensor for the long-term measurement, precise and permanent recording of ground reaction forces. Both sensors are designed to work under real-world conditions."

"We are currently focusing on the development of groundbreaking motion analysis solutions for lower back pain, osteoarthritis of knee and hip, and Parkinson´s disease," added Michael Weber, also Co-CEO of Motion Capture Group. "Our goal is to expand our pipeline to other major chronic motion-related disorders such as stroke, diabetic foot ulcers, multiple sclerosis and sport injuries of the lower limbs."

"We are impressed by MCG´s pioneering approach to analyze real-world motion signals with gold standard performance, so far only possible in expensive laboratory settings," said Dr. Franck Brinkhaus, CEO of Biotech Alliances International. "We are convinced that MCG´s digital health solution for chronic motion conditions will have a great impact on healthcare and on the pharmaceutical and medtech industries."


###


About Motion Capture Group

MCG Motion Capture Group (MCG) is a leading provider of next-generation precision motion analysis and digital health solutions. The Company´s cloud-based solutions focus on the prevention, diagnosis, analysis and alleviation of motion-related conditions and diseases. MCG´s mission is empowering people with chronic motion conditions to maintain daily activities and improve quality of life.

MCG combines unparalleled medical, digital and health economic expertise, spanning from sensor development, bioinformatics, and digital health to clinical trials and the registration and commercialization of high-quality medical devices.

With its solutions, MCG is addressing the healthcare sector (e.g. TEP post-surgery rehab management, diabetic foot ulcer, chronic back pain), the biopharmaceutical industry (e.g. MotionMarkers in clinical drug trials), occupational health management (e.g. bus, train and truck drivers) and the sports market (e.g. marathon runners). MCG is based in Heidelberg and Potsdam, Germany.


About Biotech Alliances

Biotech Alliances International Inc., is a Silicon Valley-based healthcare-focused investment bank. It provides independent financial and strategic advice including corporate finance and mergers & acquisitions.


Contact Motion Capture Group

Hartmut Voss / Michael Weber
Co-CEOs
MCG motion capture GmbH
Waldhofer Str. 102
69123 Heidelberg
info@motioncapturegroup.com
Tel. +49 331 2318 2535


Media Inquiries

akampion
Dr. Ludger Wess / Ines-Regina Buth
Managing Partners
info@akampion.com
Tel. +49 40 88 16 59 64
Tel. +49 30 23 63 27 68


Contact Biotech Alliances

Dr. Franck Brinkhaus
San Francisco/ Silicon Valley
franck.brinckhaus@biotech-alliances.com
Tel. +1 (650) 8688 851

   
Record changed: 2019-11-03

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for MCG Motion Capture GmbH (Motion Capture Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px




» top